Click on a filter below to refine your search. Remove a filter to broaden your search.
The annual inflation-adjusted health care costs of cardiovascular risk factors is projected to triple between 2020 and 2050.
However, supplements may be a risk factor for atrial fibrillation and stroke in the general population.
The findings were seen in patients with suspected acute stroke with elevated systolic blood pressure.
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Those with the lowest insulin resistance, as measured by highest estimated glucose disposal rate, had the lowest risk for stroke death.